Purchase of Shares by Director

Summary by AI BETAClose X

Craneware plc announced that its Chair, William Whitehorn, purchased 640 ordinary shares at 1,173 pence per share on July 3, 2026, for a total investment of £7,507.20. Following this transaction, Mr. Whitehorn now holds 7,140 ordinary shares, representing 0.021% of the company's issued share capital. This director's purchase of shares may be viewed positively by the market as it indicates confidence in the company's future prospects.

Disclaimer*

Craneware plc
03 July 2026
 

 

Craneware plc

 

("Craneware" or the "Company" or the "Group")

 

Purchase of Shares by Director

 

 

3 July 2026 - Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, announces that on 3 July 2026, Will Whitehorn, Chair of the Company, purchased 640 Ordinary Shares of 1p each in the capital of the Company at a price of 1,173 pence per Ordinary Share.

 

Following the purchase of Ordinary Shares, Mr. Whitehorn holds 7,140 Ordinary Shares in the capital of the Company, representing 0.021% of the Company's issued share capital (excluding Ordinary Shares held in treasury).

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:  

 

1.   Details of the Restricted Person / person closely associated with him or her

a) Name                                                             William Whitehorn

 

2.   Reason for the notification

a) Position / status                                             Chair

b) Initial notification / Amendment                       Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name                                                             Craneware plc

b) LEI                                                                213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument                                                     Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code                                           ISIN GB00B2425G68

 

c) Nature of the transaction                                    Purchase of Ordinary Shares

 

d) Price(s) and volume(s)                                      Volume(s) 640, Price(s) £11.73

 

e) Aggregated information:                                  N/A (single transaction)

                                    i. Aggregated volume             -

                                    ii. Price(s)                              -

 

f) Date of the transaction                                    2026-07-03

 

       g) Place of the transaction                                   London Stock Exchange (XLON)

 

 

 

For further information, please contact:

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO


Craig Preston, CFO




Alma Strategic Communications

+44 (0)20 3405 0205

Caroline Forde, Louisa El-Ahwal

craneware@almastrategic.com



Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Benjamin Cryer, Kate Bannatyne




Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Virginia Bull, Arnav Kapoor


  

 

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Tom Ballard, Patrick Dolaghan, Ryan Mahnke


 

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Craneware (CRW)
UK 100

Latest directors dealings